EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Early Atlantoaxial Inflammatory Involvement Detected by 18F-FDG PET/CT in Newly Diagnosed Seropositive Rheumatoid Arthritis: A Rare but Critical Presentation

Sibel Ösken

Aktuelle Rheumatologie · 2026-10-01 · 51 (05) · 292-295

DOI: 10.1055/a-2870-0178 ↗
AbstractBibliografische Angaben

Abstract

Abstract Atlantoaxial involvement is a well-recognized but typically late complication of rheumatoid arthritis (RA). Early cervical spine inflammation at disease onset is uncommon and may pose diagnostic and therapeutic challenges. A 74-year-old man presented with inflammatory polyarthritis and was diagnosed with seropositive RA based on elevated anti–cyclic citrullinated peptide antibodies (>500 U/mL) and compatible clinical findings. Initial treatment with prednisolone and leflunomide resulted in clinical improvement. Two months later, he developed severe neck pain with marked restriction of cervical motion and a significant rise in inflammatory markers (ESR 96 mm/h, CRP 68 mg/L). Infectious and malignant causes were excluded. Owing to underlying chronic renal failure, contrast-enhanced imaging was avoided. Positron emission tomography–computed tomography (PET-CT) demonstrated increased fluorodeoxyglucose (FDG) uptake at the C1–C2 level and in both glenohumeral joints, consistent with inflammatory involvement. Treatment with tocilizumab was initiated, leading to rapid clinical and laboratory remission. Follow-up cervical magnetic resonance imaging (MRI) confirmed complete resolution of inflammation. This case underscores that atlantoaxial involvement may occur early in the course of seropositive RA. PET-CT can be a valuable diagnostic modality when conventional imaging options are limited. Early recognition and targeted biologic therapy can lead to rapid remission and prevent complications.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →